3[3]Liu ks lee FY.Lee Sd et al endotoxehna ni patients with chronoc liver diseases relationship to screrty of liver disease presente of esophageal laries and hyperclynanic circwlation J Heptol 1995,22:165～172.
二级参考文献8
1Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut, 1999, 45 (Supopl Ⅱ): Ⅱ43-Ⅱ47.
2More J, Benazet J, Fioramonti J, et al. Effects of treatment with Smectite on gastric and intestinal glycoproteins in the rat: a histochemical study. Histochem J, 1987, 19 : 665-670.
3Droy-Lefaix MT, Drouet Y, Geraud G. Protective effect of Smectite on gastrointestinal biliary salts rat damage. Gastroenterology, 1988, 1 (Sup 1): 1076.
4Droy-Lefaix MT, Drouet Y, Schatz B. Sodium glycodeoxycholate and spinability of gastrointestinal mucus ; protective effect of Smectite. Gastroenterology, 1985, 88: 1369.
5Leber W. A new suspension form of smectite for the treatment of acute diarrhoea: a randomized comparative study. Pharmatherapeutica, 1988,5:256-260.
6Madkour AA, Medina EM, EI-Azzouni OE, et al. Smectite in acute diarrhea in children : a double-blind placebo-controlled clinical trial.J Pediatr Gastroenterol Nutr, 1993,17 : 176-181.
7Lachaux A, Danzon A, Collet JP, et al. Acute infantile diarrhea.Role of treatment with Smectite as a complement to rehydration.Revue Intemationale de P6diatrie, 1986,163 : 29-31 .
8Lievin V, Peiffer I, Hudalt S, et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut, 2000, 47: 646-652.
